This public procurement record has 3 releases in its history.

Award

26 Feb 2024 at 12:50

TenderUpdate

24 Oct 2023 at 11:06

Tender

24 Oct 2023 at 10:12

Summary of the contracting process

The public procurement contracting process is currently in the Tender stage by the buying organisation, focusing on the provision of construction services in the education industry category. The tender is located in London, UK, with a submission deadline of 30th September 2021. This presents an opportunity for construction companies specialising in education infrastructure projects to compete and potentially secure a contract.

The contracting authority seeking construction services for an education project in London sets a clear deadline for interested businesses to submit their bids. The competitive nature of the Tender stage allows construction companies with relevant experience in the education sector to showcase their capabilities and potentially expand their business portfolio through successful contract award.

How relevant is this notice?

Notice Title

NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

Notice Description

Project Title: NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024<br/> <br/>Offer reference number: CM/PHR/22/5678<br/> <br/>CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.<br/><br/>CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.<br/><br/>CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months<br/><br/>CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

Lot Information

CM/PHR/22/5678/01

CM/PHR/22/5678/01 - NHS Framework for North of England Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

CM/PHR/22/5678/02

NHS Framework for North of England Branded Medicines - Lot 2. (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

CM/PHR/22/5678/03

CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

CM/PHR/22/5678/04

CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-040e74
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/006097-2024
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£1,833,333,000 £1B-£10B
Lots Value
£1,833,334,000 £1B-£10B
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
26 Feb 20242 years ago
Submission Deadline
24 Nov 2023Expired
Future Notice Date
Not specified
Award Date
26 Jan 20242 years ago
Contract Period
1 Mar 2024 - 31 Aug 2025 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
LS2 7UE
Postcode Area
Leeds
Country
England

Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified

Local Authority
Leeds
Electoral Ward
Little London & Woodhouse
Westminster Constituency
Leeds Central and Headingley

Supplier Information

Number of Suppliers
38
Supplier Names

Abbvie Ltd

Accord-UK Ltd

Almirall

Amgen Ltd

AstraZeneca

Aventis Pharma ltd t/a Sanofi

Bayer Plc

Biogen

CST Pharma Limited

Celltrion Healthcare United Kingdom Limited

Chugai Pharma UK Ltd

Dr.Reddy's Laboratories (UK) Limited

Eli Lilly and Company Ltd

Galapagos Biotech Ltd

Gedeon Richter UK Ltd

GlaxoSmithKline UK Limited

Ipsen

Janssen-Cilag Ltd

Merck Serono Limited

Merck Sharpe and Dohme (UK) Limited

Merz

Mylan

Napp Pharmaceuticals Ltd

Neon Healthcare Ltd

Novartis Pharmaceuticals UK Ltd

Novo Nordisk

Organon Pharmaceuticals UK Ltd

Orifarm UK

Pfizer Ltd

Pharmacosmos UK Ltd

Roche Products Ltd

Sandoz Ltd

Sobi (Swedish Orphan Biovitrum Ltd)

Sun Pharma UK Ltd

Teva UK Limited

Thornton and Ross Ltd

Vifor Pharma UK Ltd

Zentiva Pharma UK Ltd

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...